Drug shields mice from chronic lung disease: study
By Julie Steenhuysen
CHICAGO (Reuters) - An experimental drug protected mice exposed to tobacco smoke from developing chronic lung disease, raising hope for a treatment in humans, U.S. researchers said on Monday.
They said the chemical CDDO-Im helped activate a master gene called Nrf2 that bolsters the lung’s ability to fight off chronic obstructive pulmonary disease, or COPD, a condition that includes emphysema, chronic bronchitis and some types of serious chronic asthma.
“COPD is the 4th-largest killer in the world with no effective drugs,” Shyam Biswal of Johns Hopkins School of Medicine in Maryland, who worked on the study, said in an e-mail.
In prior research, Biswal and colleagues found that Nrf2 works as a “master gene,” turning on genes involved in protecting the lungs from pollution and cigarette smoke.
“The Nrf2 pathway is the major antioxidant and detoxifying response in the lungs. Therapies targeting this pathway need to be developed and tested in patients,” said Biswal, whose study was published in the Proceedings of the National Academy of Sciences.
For the study in mice, Biswal and colleagues studied the drug compound CDDO-Im, which induces the Nrf2 gene to activate a host of antioxidant genes. “This antioxidant response detoxifies the harmful molecules that cause lung damage,” he said.
The researchers exposed mice to cigarette smoke for six months to simulate the lung damage seen in emphysema.
Mice that received the drug were protected against lung damage and also showed dramatically improved heart function compared to the untreated mice.
Privately held Reata Pharmaceuticals Inc of Irving, Texas, is studying a drug in the same class, CDDO-Me, as a potential treatment for cancer under the name RTA-402.
“Both compounds are potent Nrf2 activators. Since CDDO-Me is going through clinical trial for lung cancer, it may be used for a future clinical trial for COPD,” Biswal said.
COPD affects 210 million people worldwide. Smoking is by far the leading cause, but environmental factors such as pollution also play a role.
--------------------------------------------------------------------------------------------Related Posts:
NEW YORK (Reuters Health) - Computed tomography (CT) of the chest can serve a dual purpose in patients with chronic obstructive pulmonary disease (COPD), measuring both the severity of emphysema and vertebral bone density, physicians in Japan report. Many features besides the lung are associated with COPD, indicating it is a systemic disease, Dr. Toyohiro Hirai
Full Post: CT imaging useful to measure bone loss in COPD
--------------------------------------------------------------------------------------------
NEW YORK (Reuters Health) - Between 2000 and 2005, the number of annual deaths in the United States due to chronic obstructive pulmonary disease (COPD) rose by 8 percent, an increase driven primarily by climbing mortality rates among women with the disease, according to a report in the Morbidity and Mortality Weekly Report. Data were related
Full Post: COPD deaths increase among women
--------------------------------------------------------------------------------------------
NEW YORK (Reuters Health) - Results of a study conducted in the Asia-Pacific region suggest that men with COPD are more likely to die or be hospitalized than women with COPD. COPD, or chronic obstructive pulmonary disease, is a progressive disease that makes it hard to breathe. COPD can cause coughing that produces large amounts of
Full Post: More men than women die of COPD, study hints
--------------------------------------------------------------------------------------------
Smoking is a lifestyle choice which many people have adopted. The smoke from a cigarette can adversely affect our body. The lungs and the airways are the worst hit and sometimes the damage caused to them is irreversible. People are always advised to quit smoking due to the wide range of health effects on our
Full Post: Smoking And Lungs Damage
--------------------------------------------------------------------------------------------
HONG KONG (Reuters) - Researchers in China and the United States have identified mutations of two genes which appear to make ethnic Chinese more susceptible to lung cancer, they wrote in the journal Cancer. Their finding involves two genes, ABCB1 and ABCC1, which were previously thought to be linked to eliminating carcinogens from the lungs and
Full Post: Experts identify gene variants linked to lung cancer